Soleno Therapeutics Inc Ratios

Ratios Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 41.94%-4.03%
EBT Margin -123.51%224.89%-2,618.81%-464.41%76,125.54%
EBIT Margin -28.23%124.92%-2,001.70%-573.77%81,242.86%
EBITDA Margin -28.23%124.92%-2,001.70%-573.77%75,969.26%
Operating Margin -28.23%124.92%-2,001.70%-573.77%81,242.86%
Net Margin -123.51%224.89%-2,618.81%-1,083.30%76,125.54%
FCF Margin -29.55%109.31%-1,704.62%-931.41%30,007.79%
Efficiency
Inventory Average 0.33M
Assets Average 4.99M8.30M6.88M22.29M41.09M
Equity Average -22.69M-3.98M3.33M15.13M28.61M
Invested Capital -20.20M-11.09M4.09M3.44M26.82M30.41M
Asset Utilization Ratio -0.830.070.21
Leverage & Solvency
Interest Coverage Ratio -0.30-1.25-812.43
Debt to Equity -0.41-0.010.27
Debt Ratio 8.820.010.11
Equity Ratio -21.55-1.330.390.620.690.70
Times Interest Earned -0.30-1.25-812.43
Valuation
Enterprise Value -1.27M2.14M17.38M10.04M0.90M13.56M16.16M1,227.60M1,938.13M
Market Capitalization 10.10M22.88M12.77M18.00M36.65M16.16M1,227.60M1,938.13M
Return Ratios
Return on Sales -1.24%2.25%-26.19%-3.67%761.26%
Return on Capital Employed -1.39%-2.38%-1.61%-0.59%-0.36%
Return on Invested Capital -0.71%
Return on Assets -1.86%-1.92%-0.77%-0.16%-0.04%
Return on Equity 0.41%3.99%-1.60%-0.24%-0.05%